Loading...
Loading...
Contributors:
Dataset URI:
10.1371/journal.pntd.0013323.s005Trichinellosis is a globally distributed zoonotic parasitic disease. The Trichinella infective larvae migrate through the intestine after ingestion and settle in muscles, thus intestinal mucosal immunity plays a vital role against early infection with Trichinella. In this study, a recombinant adenovirus vector expressing the cysteine protease inhibitor of Trichinella spiralis (rAd5TsCLP) was constructed and combined with the recombinant protein rTsCLP in a heterologous prime-boost regimen. The regimen elicits strong, specific, and neutralizing antibodies in BALB/c mice, significantly enhancing cellular immunity through Th1 (IFN-γ, TNF-α) and Th2 (IL-13, IL-4) cytokine production in the peripheral blood, spleen, and cervical lymph nodes, driven by the activation of CD4+ and CD8+ T-cells. Notably, immunization with rAd5TsCLP:rTsCLP elevated mucosal secretory IgA (sIgA) levels, boosted histamine concentrations, and increased goblet cell numbers in the intestinal epithelium. Vaccinated mice showed a significant 61.17% reduction in adult worms and a 58.22% reduction in muscle larvae after the T. spiralis challenge. The adenovirus vector-delivered TsCLP amplifies local mucosal immunity, eliciting a Th1/Th2 mixed immune response that facilitates the expulsion of T. spiralis. Our study provides a feasible and promising approach for Trichinella vaccines, further highlighting the potential of an adenovirus vector for anti-helminth vaccine development.
Keyword(s):
adenovirus vector; adult worms; Biological Sciences not elsewhere classified; boost immunization based; boost regimen.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)